Long-term survival results of a randomized multinational phase 3 trial of dacarbazine (DTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients with advanced malignant melanoma

Reviewer: S. Jack Wei, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 14 de mayo del 2005

Translation for this article does not exist


Where Are the Adults in the Room?
by Rodney Warner, JD
November 20, 2015